Global Action Plan on Antimicrobial Resistance. WHO. (2015)

immage

Antimicrobial resistance threatens the very core of modern medicine and the sustainability of an effective, global public health response to the enduring threat from infectious diseases. Systematic misuse and overuse of these drugs in human medicine and food production have put every nation at risk. Few replacement products are in the pipeline. Without harmonized and immediate action on a global scale, the world is heading towards a post-antibiotic era in which common infections could once again kill.


Keywords: awareness, prevention, medicines, diagnostic, vaccines

 

Download Publication

 

Issue Brief - Decisions Around HIV Treatment in 2015: Seven Ways to Fail, Derail or Prevail. Médecins Sans Frontières. (2015)

immage

In this issue brief we first review trends in generic competition and intellectual property (IP) licensing for key antiretroviral drugs. We then outline seven momentous decisions to be made in 2015 that will largely determine whether ART will be affordable, available and robust for the next 15 years of treatment scale-up to all people living with HIV. This includes opportunities for greatly improved treatment regimens based on WHO guidelines on when to start treatment, and what first- and second line regimens should include.

 

Keywords: HIV/AIDS, Global Fund, medicines, treatment, ART

Download Publication

Overview of regional implementation of the Political Declaration on HIV/AIDS and the Millennium Development Goals and Efforts to Ensure Universal Access in Asia and the Pacific. ESCAP. (2015)

immage

The present document aims to review the progress of the HIV response in the Asia-Pacific region, with a view to identifying the opportunities for further action afforded by the 2011 Political Declaration. In doing so, it also draws on the expressed commitments undertaken by ESCAP member States to address the HIV epidemic, including those reflected in resolutions 66/10, Regional call for action to achieve universal access to HIV prevention, treatment, care and support in Asia and the Pacific (19 May 2010) and 67/9, Asia-Pacific regional review of the progress achieved in realizing the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS (25 May 2011).

 

Keywords: IGM, 2015, HIV, prevalence, treatment, care, prevention, gender, violence, ART, children, women

Download Publication

Progress for Children Beyond Averages: Learning from the MDGS. UNICEF. (2015)

immage

A child’s chance to survive and thrive is much greater in 2015 than it was when the global community committed to the MDGs in 2000.

Data show significant progress in areas such as child survival, nutrition, motherto- child transmission of HIV and primary school enrolment, among others. These are impressive achievements, but they are only part of the story.

This report also shows progress for the most vulnerable, proving that a more equitable world is within reach. But despite this progress, millions of the children in greatest need have been left behind – the most marginalized and vulnerable children whose future the MDGs were designed to safeguard.

 

Keywords: children, gender equality, child mortality, infants, maternal health

Download Publication

An Innovative Approach to Triple Elimination of Mother-to-child Transmission of HIV, Syphilis and Hepatitis B in Viet Nam. Nguyen VTT, Trang HQ, Anh NTL, et al. (2015)

immage

Viet Nam has committed to working towards the elimination of HIV mother-to-child transmission. The stated goals are to reduce the vertical transmission rate of HIV nationally to less than 5% by 2015 and to less than 2% by 2020.

Viet Nam has high hepatitis B virus (HBV) and low HIV and syphilis prevalence among pregnant women. Antenatal care (ANC) coverage is high (one visit 96,6%, three visits 87.5%)*. Prevention of mother-to-child-transmission (PMTCT) of HIV and infant hepatitis B immunization are managed by separate vertical programmes and services. It is national policy that free provider-initiated universal HIV testing is recommended to pregnant women (PW). Syphilis and hepatitis B testing are not routinely offered. This study aims at demonstrating an innovative model of combined universal screening for HIV, syphilis, and HBV for PW and treatment of infected PW in ANC to prevent vertical transmission of three infections.

 


Keywords: HIV, HBV, PMTCT, Antenatal care (ANC), pregnant women

Download Poster

Worldwide Country Situation Analysis: Response to Antimicrobial Resistance. WHO. (2015)

immage

A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective antimicrobial medicines, control of the misuse of these medicines, awareness and understanding among the general public and effective infection prevention and control programmes. 


Keywords: drug resistance, microbial, infection control, surveillance

 


Download Full report and Summary report

Scaling up HIV Treatment for MSM in Bangkok: What Does It Take? — A Modelling and Costing Study. Zhang L, Phanuphak N, Henderson K, et al. (2015)

immage

The HIV epidemic amongst men who have sex with men (MSM) in Bangkok is substantial. The population size of MSM in Bangkok is 120,000-250,000, with approximately one-third (33.5 percent) considered high-risk, characterized by their young age, multiple partnerships, frequent unprotected anal intercourse, and sexual activities around MSM hotspots. In metropolitan Bangkok, HIV prevalence among MSM reportedly increased from 21 percent to 28 percent between 2000 and 2012. The Thai Working Group of Estimation and Projection (2013) projected an estimate of 39,000 new HIV infections would occur in Thailand during 2012-2016, based on the AIDS Epidemic Model (AEM). 


Keywords: HIV, transmission, heterosexual, epidemic, infections, cost-effectiveness

Download Publication

Hepatitis C Diagnostics Technology Landscape - 1st Edition. Murtagh MM. (2015)

immage

This report describes the current continuum of testing for HCV, which is complex and expensive, which means that it is very challenging to implement in resource-limited settings. It examines the platforms/tests that are currently available across the range of required HCV testing from screening to confirmation and genotyping, fibrosis staging and treatment monitoring. The report also considers how the testing cascade for HCV may be simplified with the availability of DAAs, which would help make HCV testing attainable in resource-limited settings. Finally, it looks at the pipeline of tests/platforms for HCV that could be delivered at or near the point of patient care.

 

Keywords: HIV, HCV, treatment, testing, monitoring

Download Publication

Diagnostics Access Initiative to Achieve the 90-90-90 Treatment Target. UNAIDS. (2015)

immage

The aim of the new initiative is to leverage improved, accessible, affordable and  optimally used diagnostic technologies and strategies to ensure achievement of a bold new HIV treatment target for 2020.

 

 


Keywords: HIV, treatment cascade, testing, prevention, ART, diagnostics

Download Publication

Diagnostics Access Initiative to Achieve the 90-90-90 Treatment Target. UNAIDS. (2015)

immage

The aim of the new initiative is to leverage improved, accessible, affordable and  optimally used diagnostic technologies and strategies to ensure achievement of a bold new HIV treatment target for 2020.

 

 


Keywords: HIV, treatment cascade, testing, prevention, ART, diagnostics

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Sep
17
(17 Sep - 17 Sep)
Oct
11
Nov
14